Gene-based GWAS and biological pathway analysis of the resilience of executive functioning

被引:0
作者
Shubhabrata Mukherjee
Sungeun Kim
Vijay K. Ramanan
Laura E. Gibbons
Kwangsik Nho
M. Maria Glymour
Nilüfer Ertekin-Taner
Thomas J. Montine
Andrew J. Saykin
Paul K. Crane
机构
[1] University of Washington,Department of Medicine
[2] Center for Neuroimaging,Department of Society, Human Development and Health
[3] Department of Radiology and Imaging Sciences,Departments of Neurology and Neuroscience
[4] Indiana University School of Medicine,undefined
[5] Harvard School of Public Health,undefined
[6] Mayo Clinic Florida,undefined
来源
Brain Imaging and Behavior | 2014年 / 8卷
关键词
Memory; Executive functioning; Alzheimer’s disease; Genes; Resilience; Pathways;
D O I
暂无
中图分类号
学科分类号
摘要
Resilience in executive functioning (EF) is characterized by high EF measured by neuropsychological test performance despite structural brain damage from neurodegenerative conditions. We previously reported single nucleotide polymorphism (SNP) genome-wide association study (GWAS) results for EF resilience. Here, we report gene- and pathway-based analyses of the same resilience phenotype, using an optimal SNP-set (Sequence) Kernel Association Test (SKAT) for gene-based analyses (conservative threshold for genome-wide significance = 0.05/18,123 = 2.8 × 10−6) and the gene-set enrichment package GSA-SNP for biological pathway analyses (False discovery rate (FDR) < 0.05). Gene-based analyses found a genome-wide significant association between RNASE13 and EF resilience (p = 1.33 × 10−7). Genetic pathways involved with dendritic/neuron spine, presynaptic membrane, postsynaptic density, etc., were enriched with association to EF resilience. Although replication of these results is necessary, our findings indicate the potential value of gene- and pathway-based analyses in research on determinants of cognitive resilience.
引用
收藏
页码:110 / 118
页数:8
相关论文
共 198 条
[1]  
Benjamini Y(1995)Controlling the false discovery rate—a practical and powerful approach to multiple testing Journal of the Royal Statistical Society: Series B: Methodological 57 289-300
[2]  
Hochberg Y(2011)Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer’s disease Journal of Chemical Neuroanatomy 42 118-126
[3]  
Blalock EM(2012)Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Brain Imaging and Behavior 341 c3666-431
[4]  
Buechel HM(2010)The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 33 419-843
[5]  
Popovic J(2009)Using genome-wide pathway analysis to unravel the etiology of complex diseases Genetic Epidemiology 19 837-987
[6]  
Geddes JW(2011)Gene set analysis of SNP data: benefits, challenges, and future directions. European Journal of Human Genetics 23 980-637
[7]  
Landfield PW(2012)A composite score for executive functioning, validated in Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment Brain Imaging and Behavior 32 632-429
[8]  
Crane PK(2007)Analyzing gene expression data in terms of gene sets: methodological issues Bioinformatics 9 417-1093
[9]  
Carle A(1975)Cerebral blood flow in dementia Archives of Neurology 41 1088-179
[10]  
Gibbons LE(2008)Evidence for CALM in directing VAMP2 trafficking Traffic 72 141-890